Company: BIAF
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024163
Chunk: 32

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 32
---

  
    Pre-IPO convertible notes 
     2,900,904  
    $5.31  
     —  
     2,900,904 
  
    IPO tradeable 
     2,326,835  
     3.06  
     (725,580) 
     1,601,255 
  
    IPO non-tradeable 
     3,015,464  
     3.06  
     (311,006) 
     2,704,458 
  
    Direct offering March 8, 2024 
     1,600,000  
     1.64  
     (1,066,667) 
     533,333 
  
    Placement agent direct offering March 8, 2024 
     32,000  
     1.64  
     —  
     32,000 
  
    Inducement/direct offering August 5, 2024 
     1,752,082  
     1.50  
     (1,302,082) 
     450,000 
  
    Placement agent direct offering August 5, 2024 
     49,862  
     1.50  
     —  
     49,862 
  
    Direct offering October 21, 2024 
     2,662,782  
     1.50  
     (1,136,391) 
     1,526,391 
  
    Warrant inducement February 25, 2025 
     2,926,166  
     0.85  
     —  
     2.926.166 
  
    Public offering May 7, 2025 
     15,234,375  
     0.35  
     (70,313) 
     15,164.062 
  
    Placement agent offering May 7, 2025 
     304,687  
     0.35  
     —  
     304,687 
  
    Balance at June 30, 2025 
     32,805,157  
    $1.44  
     (4,612,039) 
     28,193,118 

Note
15. SUBSEQUENT EVENTS